Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoImmunology
Volume 9, 2020 - Issue 1
Research Article
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition
Victor Cervera-Carrascona Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, Helsinki, Finland;b TILT Biotherapeutics Ltd, Helsinki, Finland
https://orcid.org/0000-0001-6684-3666View further author information
https://orcid.org/0000-0001-6684-3666View further author information, , , , , , , , , , Tuomas Mirttid Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland;e Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland;f Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finlandhttps://orcid.org/0000-0003-0455-9891View further author information
https://orcid.org/0000-0003-0455-9891View further author information, Petrus Järvinenc Department of Urology, Helsinki University Hospital, Helsinki, Finlandhttps://orcid.org/0000-0002-3751-4609View further author information
https://orcid.org/0000-0002-3751-4609View further author information, , , Antti Rannikkoc Department of Urology, Helsinki University Hospital, Helsinki, Finlandhttps://orcid.org/0000-0002-4261-3484View further author information
https://orcid.org/0000-0002-4261-3484View further author information, , & show all